Register Login
Register to leave comments
  • News bot April 20, 2026, 11:58 a.m.

    📋 ARCUS BIOSCIENCES, INC. (RCUS) - Clinical Trial Update

    Filing Date: 2026-04-20

    Accepted: 2026-04-20 07:56:39

    Event Type: Clinical Trial Update

    Event Details:

    ARCUS BIOSCIENCES, INC. (RCUS) Announces Clinical Trial Update ARCUS BIOSCIENCES, INC. (RCUS) provided an update on its clinical development programs. Clinical Development Highlights: Clinical development progress update.

    🔬 Clinical Development Pipeline (ARCUS BIOSCIENCES, INC.):

    Product Type Development Stage Therapeutic Area Source
    Pembrolizumab DRUG Phase PHASE3 Non-small Cell Lung Cancer ClinicalTrials.gov
    AB598 DRUG Phase PHASE1 Advanced Cancer ClinicalTrials.gov
    Casdatifan DRUG Phase PHASE2 Renal Cell Carcinoma ClinicalTrials.gov
    AB801 DRUG Phase PHASE1 Advanced Cancer ClinicalTrials.gov
    Placebo Other Phase EARLY_PHASE1 Glioblastoma ClinicalTrials.gov
    Domvanalimab Other Phase EARLY_PHASE1 Glioblastoma ClinicalTrials.gov
    Zimberelimab Other Phase EARLY_PHASE1 Glioblastoma ClinicalTrials.gov
    Quemliclustat DRUG Phase PHASE1 Healthy Participants ClinicalTrials.gov
    FLOT (Fluorouracil+Leucovorin+Oxaliplatin+Docetaxel) DRUG Phase PHASE2 Adenocarcinoma Stomach ClinicalTrials.gov
    Cabozantinib DRUG Phase PHASE3 Metastatic Clear Cell Renal Cell Carcinoma ClinicalTrials.gov
    Ipilimumab DRUG Phase PHASE3 Advanced Clear Cell Renal Cell Carcinoma ClinicalTrials.gov
    Nivolumab DRUG Phase PHASE3 Advanced Clear Cell Renal Cell Carcinoma ClinicalTrials.gov
    Volrustomig DRUG Phase PHASE3 Advanced Clear Cell Renal Cell Carcinoma ClinicalTrials.gov
    Phenytoin DRUG Phase PHASE1 Healthy Participants ClinicalTrials.gov
    Itraconazole DRUG Phase PHASE1 Healthy Participants ClinicalTrials.gov
    Carboplatin DRUG Phase PHASE2 Head and Neck Squamous Cell Carcinoma ClinicalTrials.gov
    Paclitaxel DRUG Phase PHASE2 Head and Neck Squamous Cell Carcinoma ClinicalTrials.gov
    Gemcitabine DRUG Phase PHASE3 Metastatic Pancreatic Ductal Adenocarcinoma ClinicalTrials.gov
    Nab-paclitaxel DRUG Phase PHASE3 Metastatic Pancreatic Ductal Adenocarcinoma ClinicalTrials.gov
    AB521 DRUG Phase PHASE1 Advanced Clear Cell Renal Cell Carcinoma or Other Advanced Solid Tumors ClinicalTrials.gov
    zanzalintinib DRUG Phase PHASE1 Advanced Clear Cell Renal Cell Carcinoma or Other Advanced Solid Tumors ClinicalTrials.gov
    Docetaxel DRUG Phase PHASE1 Advanced Cancer ClinicalTrials.gov
    Modified FOLFIRINOX DRUG Phase PHASE2 Pancreatic Ductal Adenocarcinoma ClinicalTrials.gov
    Etrumadenant DRUG Phase PHASE2 Pancreatic Ductal Adenocarcinoma ClinicalTrials.gov
    Stereotactic body radiotherapy (SBRT) RADIATION Phase PHASE2 Pancreatic Ductal Adenocarcinoma ClinicalTrials.gov
    Cisplatin DRUG Phase PHASE2 Biliary Tract Carcinoma ClinicalTrials.gov
    Stereotactic Body Radiation Therapy RADIATION Phase PHASE2 Oligometastatic Prostate Cancer ClinicalTrials.gov
    Oxaliplatin DRUG Phase PHASE1 Advanced Cancer ClinicalTrials.gov
    Leucovorin DRUG Phase PHASE1 Advanced Cancer ClinicalTrials.gov
    Fluorouracil DRUG Phase PHASE1 Advanced Cancer ClinicalTrials.gov
    Leucovorin Calcium DRUG Phase PHASE1 Borderline Resectable Pancreatic Adenocarcinoma ClinicalTrials.gov
    Irinotecan DRUG Phase PHASE1 Borderline Resectable Pancreatic Adenocarcinoma ClinicalTrials.gov
    Core Biopsy PROCEDURE Phase PHASE1 Borderline Resectable Pancreatic Adenocarcinoma ClinicalTrials.gov
    Computed Tomography PROCEDURE Phase PHASE1 Borderline Resectable Pancreatic Adenocarcinoma ClinicalTrials.gov
    Biospecimen Collection PROCEDURE Phase PHASE1 Borderline Resectable Pancreatic Adenocarcinoma ClinicalTrials.gov
    Platinum-Based Doublet DRUG Phase PHASE2 Advanced Non-Small Cell Lung Cancer ClinicalTrials.gov
    Pemetrexed DRUG Phase PHASE2 Lung Cancer ClinicalTrials.gov
    Etrumadenant (ETRUMA) DRUG Phase PHASE2 Lung Cancer ClinicalTrials.gov
    Sacituzumab govitecan-hziy (SG) DRUG Phase PHASE2 Lung Cancer ClinicalTrials.gov
    Domvanalimab (DOM) DRUG Phase PHASE2 Lung Cancer ClinicalTrials.gov
    Zimberelimab (ZIM) DRUG Phase PHASE2 Lung Cancer ClinicalTrials.gov
    Capecitabine DRUG Phase PHASE3 Advanced Upper Gastrointestinal Tract Adenocarcinoma ClinicalTrials.gov
    FOLFIRI DRUG Phase PHASE1 Pancreatic Cancer ClinicalTrials.gov
    APX005M DRUG Phase PHASE1 Pancreatic Cancer ClinicalTrials.gov
    [14C]-etrumadenant DRUG Phase PHASE1 Healthy Participants ClinicalTrials.gov
    Durvalumab DRUG Phase PHASE3 Non-Small Cell Lung Cancer ClinicalTrials.gov
    SRF617 DRUG Phase PHASE2 Metastatic Castration-resistant Prostate Cancer ClinicalTrials.gov
    Midazolam DRUG Phase PHASE1 Healthy Participants ClinicalTrials.gov
    Zimberelimab (AB122) DRUG Phase PHASE2 Rectal Cancer ClinicalTrials.gov
    FOLFOX regimen DRUG Phase PHASE2 Rectal Cancer ClinicalTrials.gov
    Radiation therapy RADIATION Phase PHASE2 Rectal Cancer ClinicalTrials.gov
    Etrumadenant (AB928) DRUG Phase PHASE2 Rectal Cancer ClinicalTrials.gov
    Radiation RADIATION Phase PHASE1 Head and Neck Cancer ClinicalTrials.gov
    AB308 DRUG Phase PHASE1 Advanced Solid Tumor ClinicalTrials.gov
    Regorafenib DRUG Phase PHASE1 Metastatic Colorectal Cancer ClinicalTrials.gov
    m-FOLFOX-6 regimen DRUG Phase PHASE1 Metastatic Colorectal Cancer ClinicalTrials.gov
    Bevacizumab DRUG Phase PHASE1 Metastatic Colorectal Cancer ClinicalTrials.gov
    AB680 DRUG Phase PHASE1 Metastatic Colorectal Cancer ClinicalTrials.gov
    SG DRUG Phase PHASE1 Prostatic Neoplasms, Castration-Resistant ClinicalTrials.gov
    Enzalutamide DRUG Phase PHASE1 Prostatic Neoplasms, Castration-Resistant ClinicalTrials.gov
    Tocilizumab DRUG Phase PHASE2 Prostate Adenocarcinoma ClinicalTrials.gov
    Atezolizumab DRUG Phase PHASE2 Prostate Adenocarcinoma ClinicalTrials.gov
    mFOLFOX DRUG Phase PHASE1 GastroEsophageal Cancer ClinicalTrials.gov
    nanoparticle albumin-bound paclitaxel (NP) DRUG Phase PHASE1 TNBC - Triple-Negative Breast Cancer ClinicalTrials.gov
    Pegylated liposomal doxorubicin (PLD) DRUG Phase PHASE1 TNBC - Triple-Negative Breast Cancer ClinicalTrials.gov
    IPI-549 DRUG Phase PHASE1 TNBC - Triple-Negative Breast Cancer ClinicalTrials.gov

    💼 Business Developments:

    • Partnership
    • Acquisition: Not available
    • Licensing: Not available
    • Regulatory Approval: Not available
    • Executive Changes: Not available

    Structured Data:

    • Company Name: ARCUS BIOSCIENCES, INC.
    • Ticker Symbol: RCUS

Search

News categories